InvestorsHub Logo
Followers 594
Posts 20577
Boards Moderated 0
Alias Born 02/01/2012

Re: senderos post# 100697

Wednesday, 04/30/2014 8:50:54 AM

Wednesday, April 30, 2014 8:50:54 AM

Post# of 399873
Elite’s 1st Generation Triple Patents and their Purpose

Many Shareholders have asked that I post a simple easy to read non-technical clarification of $ELTP 1st generation 3 Patents.




Elite’s 1st Generation Patents

8,182,836 Patent….Patent Application 12/478,952
8,425,933 Patent….Patent Application 12/640,344
8,703,186 Patent….Patent Application 13/863,764




8,182,836 Patent….Patent Application 12/478,952

This is the 1st of the Triple Patents and has been awarded to $ELTP based on its ADT Pharmacological approach of neutralizing opioid agonist abuse with an opioid antagonist that have been administered together.



8,425,933 Patent….Patent Application 12/640,344

This is the 2nd of the Triple Patents and has been awarded to $ELTP based on its 2-bead modular approach of identical physical attributes for separate agonist bead and an antagonist bead. This 2-bead tech is $ELTP Preferred Embodiment and is graphically illustrated on $ELTP website.

http://www.elitepharma.com/How_AR_Tech_Works.pdf


8,703,186 Patent….Patent Application 13/863,764


This is the 3rd of the Triple Patents and has been awarded to $ELTP based specifically on the manufacturer details for the 50 mg Naltrexone bead and its sequestering polymer to absolutely minimize Naltrexone leakage. The 50 mg Naltrexone bead is premade and can be used with any agonist opioid both type and expected dosage ranging up to 24 HR ER. The Preferred Embodiment supports the 2-bead modular technology outlined in $ELTP’s 8,425,933 Patent where unidentifiable agonist and antagonist beads are mixed together in one capsule.

In addition general broad-brush reference is made to a non-modular single bead technology manufactured with layering the agonist on to the antagonist but no specific manufacturing illustrations are given that can actually be patented. So it remains as a trade-secret or basis for a possible future single bead patent or simply $ELTP keeping its R&D “possibilities” open.

I hope this helps explains the reasons for the 3 patents. I will over time update this explanation as needed. Any questions please ask.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ELTP News